Chlamydia (Chlamydia trachomatis serovars D-K) |
Commonly asymptomatic, mild proctitis, cervicitis, vaginitis, urethritis |
Nucleic acid amplification test (NAAT) from rectal, endocervical or urethral swab specimens |
Azithromycin 1 g orally in a single dose |
OR |
Doxycycline 100 mg orally twice a day for 7 d |
Gonorrhea (Neisseria gonorrhoeae) |
Lower abdominal pain, diarrhea, rectal bleeding, tenesmus, purulent rectal discharge, urethral discharge and/or pharyngeal infection |
Gram stain (Gram-negative diplococci) and bacterial culture from anogential and pharyngeal swab |
Ceftriaxone 250 mg IM in a single dose |
PLUS |
Azithromycin 1 g orally in a single dose |
Herpes simplex virus (Herpes simplex virus) |
Painful multiple vesicular or ulcerative lesions at perianal skin and anal canal, painful defecation, fever |
Viral culture or polymerase chain reaction (PCR) from vesicular lesions |
Acyclovir 400 mg orally three times a day for 7-10 d |
OR |
Acyclovir 200 mg orally five times a day for 7-10 d |
Syphilis (Treponema pallidum) |
Depending on the stage of infection - Primary syphilis: painless ulcers or chancre in the anorectal region |
Darkfield examination and test to detect T. pallidum from lesion exudate or tissue |
Benzathine penicillin G 2.4 million unit IM in a single dose |
Secondary syphilis: maculopapular rash, condyloma lata, snail-track ulcer and mucous patch at the rectum, lymphadenopathy |
OR |
Ceftriaxone 1-2 g either IV or IM for 10-14 d |
OR |
Doxycycline 100 mg orally twice a day for 14 d |
Lymphogranuloma venereum (Chlamydia trachomatis serovars L1, L2 and L3) |
Anal pain, mucous or bloody rectal discharge, anorectal ulcer, fever, inguinal or femoral lymphadenopathy |
Culture, direct immunofluorescence or nucleic acid detection form rectal lesion and lymph node specimen |
Doxycycline 100 mg orally twice a day for 21 d |
OR |
Erythromycin base 500 mg oral four times a day for 21 d |